4.6 Article

Outcome of renal replacement therapy in the very elderly

Journal

NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 16, Issue 1, Pages 128-133

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ndt/16.1.128

Keywords

end-stage renal disease; outcome; renal replacement therapy; survival; very elderly

Ask authors/readers for more resources

Background. In a retrospective case-note and computer database analysis we assessed the outcome of very elderly patients (greater than or equal to 75 years old) with end-stage renal disease (ESRD) on renal replacement therapy (RRT). Methods. Fifty-eight individuals aged 75 or over (group 1) commenced RRT between 1 January 1991 and 31 December 1995. Comparisons were made with other patients commencing RRT who were divided into two groups: group 2 (201 individuals 65-74 years old) and group 3 (379 patients <65 years old). All subjects were followed up until the point of assessment (30 June 1998), the time of death, or withdrawal from dialysis. Survival rates in the three groups were compared using Kaplan-Meier method. The number of hospital admissions, length of in-patient stay, and complications rate on RRT were assessed for group 1. Results. One-year survival rates in groups 1, 2 and 3 were 53.5, 72.6, and 90.6% respectively and the 5-year survival rates were 2.4, 18.8, and 61.4% respectively. The very elderly spent 20% of their time in hospital, 46% had two co-morbid factors at the outset, and 26% developed multiple complications while on RRT. Withdrawal from dialysis remained the most common cause of death in this group of individuals (38%), followed by cardiovascular causes (24%) and infections (22%). Conclusion. Very elderly ESRD patients on RRT have a very poor outcome and, since they are the largest growing group of RRT patients, this has important implications for future health policies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available